Tirosint
- Product NDC
- 71858-0150
- Requested package NDC
- 71858-0150-1
- 11-digit product format
- 718580150
- Labeler code
- 71858
- Product ID
- 71858-0150_4e04737b-8d88-7c75-e063-6394a90a34c0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- IBSA Pharma Inc.
- Application
- NDA206977
- Marketing category
- NDA
- Marketing start
- 2019-03-01
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 150 ug/mL
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 71858-0150 | 71858-0150-1 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N206977-001 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 13MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-002 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 25MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-003 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 50MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-004 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 75MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-005 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 88MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-006 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 100MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-007 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 112MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-008 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 125MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-009 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 137MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-010 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 150MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-011 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 175MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | |
| N206977-012 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 200MCG/ML | SOLUTION / ORAL | RLD, RS | 2016-12-15 | |
| N206977-013 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 37.5MCG/ML | SOLUTION / ORAL | RLD | 2021-01-13 | |
| N206977-014 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 44MCG/ML | SOLUTION / ORAL | RLD | 2021-01-13 | |
| N206977-015 | TIROSINT-SOL | LEVOTHYROXINE SODIUM | 62.5MCG/ML | SOLUTION / ORAL | RLD | 2021-01-13 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N206977-001 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-001 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-001 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-001 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-001 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-002 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-002 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-002 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-002 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-002 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-003 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-003 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-003 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-003 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-003 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-004 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-004 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-004 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-004 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-004 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-005 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-005 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-005 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-005 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-005 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-006 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-006 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-006 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-006 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-006 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-007 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-007 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-007 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-007 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-007 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-008 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-008 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-008 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-008 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-008 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-009 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-009 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-009 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-009 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-009 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-010 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-010 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-010 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-010 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-010 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-011 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-011 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-011 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-011 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-011 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-012 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | |
| N206977-012 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-012 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-012 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-012 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-013 | 10537538 | 2037-02-28 | Drug product | 2022-04-20 | |
| N206977-013 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-013 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-013 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-013 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-014 | 10537538 | 2037-02-28 | Drug product | 2022-04-20 | |
| N206977-014 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-014 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-014 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-014 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 | |
| N206977-015 | 10537538 | 2037-02-28 | Drug product | 2022-04-20 | |
| N206977-015 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | |
| N206977-015 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | |
| N206977-015 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | |
| N206977-015 | 12564565 | 2044-09-26 | Drug product | 2026-03-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N206977-001 | TIROSINT-SOL | 13MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-002 | TIROSINT-SOL | 25MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-003 | TIROSINT-SOL | 50MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-004 | TIROSINT-SOL | 75MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-005 | TIROSINT-SOL | 88MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-006 | TIROSINT-SOL | 100MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-007 | TIROSINT-SOL | 112MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-008 | TIROSINT-SOL | 125MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-009 | TIROSINT-SOL | 137MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-010 | TIROSINT-SOL | 150MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-011 | TIROSINT-SOL | 175MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-012 | TIROSINT-SOL | 200MCG/ML | SOLUTION / ORAL | RLD, RS | 2016-12-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-013 | TIROSINT-SOL | 37.5MCG/ML | SOLUTION / ORAL | RLD | 2021-01-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-014 | TIROSINT-SOL | 44MCG/ML | SOLUTION / ORAL | RLD | 2021-01-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-015 | TIROSINT-SOL | 62.5MCG/ML | SOLUTION / ORAL | RLD | 2021-01-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-001 | TIROSINT-SOL | 13MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-002 | TIROSINT-SOL | 25MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-003 | TIROSINT-SOL | 50MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-004 | TIROSINT-SOL | 75MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-005 | TIROSINT-SOL | 88MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-006 | TIROSINT-SOL | 100MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-007 | TIROSINT-SOL | 112MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-008 | TIROSINT-SOL | 125MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-009 | TIROSINT-SOL | 137MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-010 | TIROSINT-SOL | 150MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-011 | TIROSINT-SOL | 175MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-012 | TIROSINT-SOL | 200MCG/ML | SOLUTION / ORAL | RLD, RS | 2016-12-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-013 | TIROSINT-SOL | 37.5MCG/ML | SOLUTION / ORAL | RLD | 2021-01-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-014 | TIROSINT-SOL | 44MCG/ML | SOLUTION / ORAL | RLD | 2021-01-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N206977-015 | TIROSINT-SOL | 62.5MCG/ML | SOLUTION / ORAL | RLD | 2021-01-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206977-001 | TIROSINT-SOL | 13MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206977-002 | TIROSINT-SOL | 25MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206977-003 | TIROSINT-SOL | 50MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206977-004 | TIROSINT-SOL | 75MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206977-005 | TIROSINT-SOL | 88MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206977-006 | TIROSINT-SOL | 100MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206977-007 | TIROSINT-SOL | 112MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206977-008 | TIROSINT-SOL | 125MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206977-009 | TIROSINT-SOL | 137MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N206977-010 | TIROSINT-SOL | 150MCG/ML | SOLUTION / ORAL | RLD | 2016-12-15 | 6a471c1ec25d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N206977-001 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-001 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-001 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-001 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-002 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-002 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-002 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-002 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-003 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-003 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-003 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-003 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-004 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-004 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-004 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-004 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-005 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-005 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-005 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-005 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-006 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-006 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-006 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-006 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-007 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-007 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-007 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-007 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-008 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-008 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-008 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-008 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-009 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-009 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-009 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-009 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-010 | 10537538 | 2037-02-28 | Drug product | 2020-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-010 | 11096913 | 2037-02-28 | Drug product | 2021-09-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-010 | 11241382 | 2039-09-17 | U-3758 | 2023-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N206977-010 | 11241382 | 2039-09-17 | U-3757 | 2023-12-14 | 011fe1cb6892… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tirosint
- Brand name suffix
- SOL
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LEVOTHYROXINE SODIUM | 150 ug/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9J765S329G | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2056462 | Internal RxNorm lookup |
| 2056466 | Internal RxNorm lookup |
| 2056468 | Internal RxNorm lookup |
| 2056470 | Internal RxNorm lookup |
| 2056472 | Internal RxNorm lookup |
| 2056474 | Internal RxNorm lookup |
| 2056476 | Internal RxNorm lookup |
| 2056478 | Internal RxNorm lookup |
| 2056480 | Internal RxNorm lookup |
| 2056482 | Internal RxNorm lookup |
| 2056484 | Internal RxNorm lookup |
| 2056486 | Internal RxNorm lookup |
| 2056488 | Internal RxNorm lookup |
| 2056490 | Internal RxNorm lookup |
| 2056492 | Internal RxNorm lookup |
| 2056494 | Internal RxNorm lookup |
| 2056496 | Internal RxNorm lookup |
| 2056498 | Internal RxNorm lookup |
| 2056500 | Internal RxNorm lookup |
| 2056502 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5d378add-f13d-40f2-99dc-0f2340ab44b7 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 97c252d3-9bb8-4530-bb44-9824dc7cf556 | Product name | 6 | 20250729 |
| 6c43b71c-35e6-4db3-ba24-c6ef42ff7003 | Product name | 3 | 20240207 |
| 890fd4bf-1a80-42b7-be1b-2d0259d5f0c8 | Product name | 5 | 20240207 |
| c8ad26bf-af73-460b-b74e-1eff16cc4f9f | Product name | 5 | 20240207 |
| 01383843-4069-43cf-aa76-dc17a6f9f8c4 | Product name | 2 | 20230123 |
| 978cca7d-a938-4791-8322-da48d90a63ef | Product name | 1 | 20230113 |
| 65f86ba3-8816-4e12-899b-18290c8de551 | Product name | 2 | 20210614 |
| f16ab90f-08c2-40be-a543-66d9827cd1f3 | Product name | 1 | 20210601 |
| 6a33ec05-2ae2-45e5-ab82-2d94b3303923 | Product name | 1 | 20190709 |
| 93355a10-1c44-4c92-a11d-7d995e0200d9 | Product name | 1 | 20190219 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71858-0150-1 | TirosintSOL | 2 in 1 CARTON | SOLUTION | 2 | 18 | |
| 71858-0150-2 | TirosintSOL | 6 in 1 CARTON | SOLUTION | 6 | 18 | |
| 71858-0150-4 | TirosintSOL | 5 in 1 POUCH | SOLUTION | 5 | 18 | |
| 71858-0150-5 | TirosintSOL | 6 in 1 CARTON | SOLUTION | 6 | 18 | |
| 71858-0150-6 | TirosintSOL | 1 mL in 1 AMPULE | SOLUTION | 1 | 18 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71858-0150-4 | ML - Milliliter | 71858-0150 | 787d6166-f513-498b-aaac-eadad240aa21 | 1 | 2019-03-12 |
| 71858-0150-5 | ML - Milliliter | 71858-0150 | de47d85e-1eb7-4997-86a5-8861a88379d3 | 1 | 2019-03-12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71858-0150 | TIROSINT SOL (LEVOTHYROXINE SODIUM) SOLUTION [IBSA PHARMA INC.] | 16 | Current NDC, Legacy NDC, 5 package rows | 20241025_5d378add-f13d-40f2-99dc-0f2340ab44b7.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tirosint SOL | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 206977 NDA206977 71858-0150-1 71858-0150 71858015001 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2056480 | levothyroxine sodium 100 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056484 | levothyroxine sodium 112 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056488 | levothyroxine sodium 125 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056492 | levothyroxine sodium 13 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056496 | levothyroxine sodium 137 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056500 | levothyroxine sodium 150 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056504 | levothyroxine sodium 175 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056508 | levothyroxine sodium 200 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056462 | levothyroxine sodium 25 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566613 | levothyroxine sodium 37.5 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566617 | levothyroxine sodium 44 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056468 | levothyroxine sodium 50 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566608 | levothyroxine sodium 62.5 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056472 | levothyroxine sodium 75 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056476 | levothyroxine sodium 88 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056482 | TIROSINT - SOL 100 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056486 | TIROSINT - SOL 112 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056490 | TIROSINT - SOL 125 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056494 | TIROSINT - SOL 13 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056498 | TIROSINT - SOL 137 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056502 | TIROSINT - SOL 150 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056506 | TIROSINT - SOL 175 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056510 | TIROSINT - SOL 200 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056466 | TIROSINT - SOL 25 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566615 | TIROSINT - SOL 37.5 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566619 | TIROSINT - SOL 44 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056470 | TIROSINT - SOL 50 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566610 | TIROSINT - SOL 62.5 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056474 | TIROSINT - SOL 75 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056478 | TIROSINT - SOL 88 MCG in 1 mL Oral Solution | PSN | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056494 | levothyroxine sodium 0.013 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056466 | levothyroxine sodium 0.025 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566615 | levothyroxine sodium 0.0375 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566619 | levothyroxine sodium 0.044 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056470 | levothyroxine sodium 0.05 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566610 | levothyroxine sodium 0.0625 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056474 | levothyroxine sodium 0.075 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056478 | levothyroxine sodium 0.088 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056482 | levothyroxine sodium 0.1 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056486 | levothyroxine sodium 0.112 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056490 | levothyroxine sodium 0.125 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056498 | levothyroxine sodium 0.137 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056502 | levothyroxine sodium 0.15 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056506 | levothyroxine sodium 0.175 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056510 | levothyroxine sodium 0.2 MG/ML Oral Solution [Tirosint] | SBD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056492 | levothyroxine sodium 0.013 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056462 | levothyroxine sodium 0.025 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566613 | levothyroxine sodium 0.0375 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566617 | levothyroxine sodium 0.044 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056468 | levothyroxine sodium 0.05 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566608 | levothyroxine sodium 0.0625 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056472 | levothyroxine sodium 0.075 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056476 | levothyroxine sodium 0.088 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056480 | levothyroxine sodium 0.1 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056484 | levothyroxine sodium 0.112 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056488 | levothyroxine sodium 0.125 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056496 | levothyroxine sodium 0.137 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056500 | levothyroxine sodium 0.15 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056504 | levothyroxine sodium 0.175 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056508 | levothyroxine sodium 0.2 MG/ML Oral Solution | SCD | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056480 | levothyroxine sodium 100 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056484 | levothyroxine sodium 112 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056488 | levothyroxine sodium 125 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056492 | levothyroxine sodium 13 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056496 | levothyroxine sodium 137 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056504 | levothyroxine sodium 175 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056508 | levothyroxine sodium 200 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056462 | levothyroxine sodium 25 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056468 | levothyroxine sodium 50 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056472 | levothyroxine sodium 75 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056476 | levothyroxine sodium 88 MCG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566615 | Tirosint 0.0375 MG/ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566619 | Tirosint 0.044 MG/ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2566610 | Tirosint 0.0625 MG/ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056494 | Tirosint SOL 0.013 MG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056466 | Tirosint SOL 0.025 MG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056470 | Tirosint SOL 0.05 MG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056474 | Tirosint SOL 0.075 MG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056478 | Tirosint SOL 0.088 MG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
| 2056482 | Tirosint SOL 0.1 MG per 1 ML Oral Solution | SY | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 18 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71858-0150-1 | 71858015001 | 2 POUCH in 1 CARTON (71858-0150-1) > 5 AMPULE in 1 POUCH (71858-0150-4) > 1 mL in 1 AMPULE (71858-0150-6) | 2 pouch | 2019-03-01 | 0000-00-00 | No | No | Current |